Brief: Theravance Biopharma Announces Tender Offer For Up To $95 Million Of Its Ordinary Shares
Sept 28 (Reuters) - Theravance Biopharma Inc TBPH.O :
* THERAVANCE BIOPHARMA INC - THERAVANCE BIOPHARMA ANNOUNCES
TENDER
OFFER FOR UP TO $95 MILLION OF ITS ORDINARY SHARES
* THERAVANCE BIOPHARMA INC - PAR VALUE $0.00001 PER SHARE
* THERAVANCE BIOPHARMA INC - PURCHASE PRICE NOT GREATER THAN
$10.50 NOR LESS THAN $9.75 PER SHARE
Source text for Eikon: ID:nPn6Z0sNka
Further company coverage: TBPH.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions